Cargando…

Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1–34)

Detalles Bibliográficos
Autores principales:	Elder, Grahame, Kumar, Karthic S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477913/ https://www.ncbi.nlm.nih.gov/pubmed/28657007 http://dx.doi.org/10.1093/ndtplus/sfn008

Ejemplares similares

Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH
por: Vavanikunnel, Janina, et al.
Publicado: (2022)

Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment
por: Fowler, Tristan W., et al.
Publicado: (2012)

PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022)

Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism
por: Fuss, Carmina Teresa, et al.
Publicado: (2020)

Chronic Kidney Disease and Calciphylaxis: A Literature Review
por: Ahmed, Munis M, et al.
Publicado: (2018)

Diagnosis and treatment of calciphylaxis in patients with chronic kidney disease
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
por: Salave, Sagar, et al.
Publicado: (2023)

Interactome of PTH-Regulated miRNAs and Their Predicted Target Genes for Investigating the Epigenetic Effects of PTH (1–34) in Bone Metabolism
por: Vrščaj, Lucija Ana, et al.
Publicado: (2022)

Calciphylaxis After Kidney Transplant
por: Ryan, Michael P, et al.
Publicado: (2019)

Calciphylaxis: Challenges in the diagnosis and management
por: Sahu, Kamal Kant, et al.
Publicado: (2019)

Bone scintigraphy findings in calciphylaxis
por: Raduka, John, et al.
Publicado: (2018)

Management of Cutaneous Calciphylaxis
por: Kodumudi, Vijay, et al.
Publicado: (2020)

Calciphylaxis: Successful Management of a Rare Complication of Chronic Kidney Disease in Two Patients
por: Fares, Ibtissam, et al.
Publicado: (2019)

Enhanced bone regeneration via local low-dose delivery of PTH(1-34) in a composite hydrogel
por: Zhang, Shanyong, et al.
Publicado: (2023)

Calciphylaxis presenting in early chronic kidney disease with mixed hyperparathyroidism
por: Brucculeri, Michael, et al.
Publicado: (2011)

Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling
por: Pawlak, Krystyna, et al.
Publicado: (2021)

Management of chronic urinary retention in glanular penile calciphylaxis
por: Rahman, Syed, et al.
Publicado: (2022)

PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss
por: Che, Jingmin, et al.
Publicado: (2023)

Challenges management in penile calciphylaxis
por: Swatesutipun, Valeerat, et al.
Publicado: (2022)

Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2021)

Overexpression of Recombinant Human Teriparatide, rhPTH (1–34) in Escherichia coli : An Innovative Gene Fusion Approach
por: Bakhtiari, Nahid, et al.
Publicado: (2017)

Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case Report
por: Welte, Thomas, et al.
Publicado: (2016)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34)
por: Le Henaff, Carole, et al.
Publicado: (2023)

Calciphylaxis
por: Mulrow, Patrick J.
Publicado: (1962)

Calciphylaxis
por: Neild, G. H., et al.
Publicado: (2013)

Calciphylaxis
por: Harb, Jennifer, et al.
Publicado: (2015)

Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)
por: Ren, Yongxin, et al.
Publicado: (2011)

Recombinant PTH associated with hypercalcaemia and renal failure
por: Ayasreh, Nadia, et al.
Publicado: (2013)

Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients
por: Einbinder, Yael, et al.
Publicado: (2017)

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
por: Generali, D, et al.
Publicado: (2008)

Simultaneous incorporation of PTH(1–34) and nano-hydroxyapatite into Chitosan/Alginate Hydrogels for efficient bone regeneration
por: Zou, Zhiyuan, et al.
Publicado: (2020)

Graphene Oxide/RhPTH(1-34)/Polylactide Composite Nanofibrous Scaffold for Bone Tissue Engineering
por: Fei, Fan, et al.
Publicado: (2023)

Bone histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic bone disease subsequent to parathyroidectomy
por: Lehmann, Gabriele, et al.
Publicado: (2009)

Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide, hPTH(1-34), on Bone Formation and Resorption in Ovariectomized Rats
por: Isogai, Yukihiro, et al.
Publicado: (2015)

A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease
por: Hampson, Geeta, et al.
Publicado: (2021)

Calciphylaxis following kidney transplantation: a case report
por: Hanvesakul, Rajesh, et al.
Publicado: (2009)

Calciphylaxis of the fingers
por: Harada, Ko, et al.
Publicado: (2020)

Penile calciphylaxis
por: Bath, Kulwant, et al.
Publicado: (2020)

Non-Uremic Calciphylaxis: An Unexpected Complication With Recombinant Human Parathyroid Hormone
por: DeClue, Cory, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ee1j69sdkc640qib4svi9aodf